Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).

Saved in:
Bibliographic Details
Title: Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC).
Authors: Di Costanzo, F.1 dicostanzofrancesco@tiscali.it, Carlini, P.2, Doni, L.1, Massidda, B.3, Mattioli, R.4, Iop, A.5, Barletta, E.6, Moscetti, L.7, Recchia, F.8, Tralongo, P.9, Gasperoni, S.1
Source: British Journal of Cancer. 7/25/2005, Vol. 93 Issue 2, p185-189. 5p.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6602640